AB0174 EFFECTS OF ONE-YEAR ANTI-TNF-α THERAPY ON NATURAL AUTOANTIBODIES IN ASSOCIATION WITH VASCULAR PATHOPHYSIOLOGY IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS Z Szekanecz, D Simon, D Kacsándi, A Pusztai, B Soós, E Végh, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 1321-1321, 2024 | | 2024 |
2023 EULAR classification criteria for hand osteoarthritis IK Haugen, DT Felson, A Abhishek, F Berenbaum, S Bierma-Zeinstra, ... Annals of the rheumatic diseases, 2024 | | 2024 |
Twenty shades of the mosaic of autoimmunity Z Szekanecz Autoimmunity Reviews, 103575, 2024 | | 2024 |
Can we define difficult-to-treat systemic sclerosis? G Szűcs, Z Szekanecz, S Szamosi Expert Review of Clinical Immunology, 1-17, 2024 | | 2024 |
Monogenic and acquired autoinflammatory diseases Z Szekanecz, S Szamosi, S Benkő, G Szűcs Orvosi hetilap 165 (18), 683-697, 2024 | | 2024 |
Monogénesen öröklődő és szerzett autoinflammatoricus betegségek Z Szekanecz, S Szamosi, S Benkő, G Szűcs Orvosi Hetilap 165 (18), 683-697, 2024 | | 2024 |
Granulomatosis with polyangiitis or its mimic? A case report T Major, G Nagy, J Szabó, H Mózes, G Szűcs, Z Szekanecz, S Szamosi Journal of International Medical Research 52 (4), 03000605241237876, 2024 | | 2024 |
Distinct subsets of anti-pulmonary autoantibodies correlate with disease severity and survival in severe COVID-19 patients E Tóth, M Fagyas, B Nagy Jr, IM Siket, B Szőke, L Mártha, M Mahdi, ... GeroScience 46 (2), 1561-1574, 2024 | | 2024 |
Natural Autoantibodies in Biologic-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients: Associations with Vascular Pathophysiology D Simon, D Kacsándi, A Pusztai, B Soós, E Végh, G Kerekes, M Bodoki, ... International Journal of Molecular Sciences 25 (6), 3429, 2024 | | 2024 |
Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk‐Enriched Rheumatoid Arthritis Patients C Charles‐Schoeman, R Fleischmann, E Mysler, M Greenwald, ... Arthritis & Rheumatology, 2024 | 2 | 2024 |
Current status of immunological therapies for rheumatoid arthritis with a focus on antigen-specific therapeutic vaccines DH Zimmerman, Z Szekanecz, A Markovics, KS Rosenthal, ... Frontiers in immunology 15, 1334281, 2024 | | 2024 |
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician Z Szekanecz, MH Buch, C Charles-Schoeman, J Galloway, ... Nature Reviews Rheumatology 20 (2), 101-115, 2024 | 7 | 2024 |
Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseases PC Taylor, E Choy, X Baraliakos, Z Szekanecz, RM Xavier, JD Isaacs, ... Rheumatology 63 (2), 298-308, 2024 | 8 | 2024 |
A novel way to evaluate autoantibody interference in samples with mixed antinuclear antibody patterns in the HEp-2 cell based indirect immunofluorescence assay and comparison … G Nagy, R Földesi, I Csípő, T Tarr, G Szűcs, A Szántó, T Bubán, ... Clinica Chimica Acta 553, 117747, 2024 | | 2024 |
Six-Month Follow-Up of Periodontal Condition in Rheumatoid Arthritis and Ankylosing Spondylitis Arthritis Patients Undergoing Anti-Tumour Necrosis Factor-α Therapy I Tar, E Végh, R Martos, B Soós, I Márton, Z Szekanecz Journal of Clinical Medicine 13 (2), 448, 2024 | | 2024 |
Letter to the editor & Book review Z Szekanecz, Á Illés, T Tarr, L Kiss Orvosi hetilap 164 (52), 2085-2088, 2023 | | 2023 |
Levél a szerkesztőhöz & Könyvismertetés Z Szekanecz, Á Illés, T Tarr, L Kiss Orvosi Hetilap 164 (52), 2085-2088, 2023 | | 2023 |
" More on the Szegedi Road": Ten years after the death of Professor Gyula Szegedi (1936-2013) Z Szekanecz, A Illes, T Tarr ORVOSI HETILAP 164 (52), 2085-2086, 2023 | | 2023 |
Autoimmun reumatológiai kórképek és pulmonális hypertonia a reumatológus szemszögébôl. S GABRIELLA, H ÁGNES, T DÓRA, S ZOLTÁN, S SZILVIA Immunology Quaterly/Immunologiai Szemle 15 (4), 2023 | | 2023 |
A JAK-gátlók biztonságossága rheumatoid arthritisben–amit a gyakorló klinikusnak tudni érdemes. S ZOLTÁN Immunology Quaterly/Immunologiai Szemle 15 (4), 2023 | | 2023 |